365 related articles for article (PubMed ID: 12163269)
1. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
[TBL] [Abstract][Full Text] [Related]
2. Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.
Hel Z; Tryniszewska E; Tsai WP; Johnson JM; Harrod R; Fullen J; Kalyanaraman VS; Altman JD; McNally J; Karpova T; Felber BK; Tartaglia J; Franchini G
DNA Cell Biol; 2002 Sep; 21(9):619-26. PubMed ID: 12396604
[TBL] [Abstract][Full Text] [Related]
3. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
4. Immunological and virological analyses of rhesus macaques immunized with chimpanzee adenoviruses expressing the simian immunodeficiency virus Gag/Tat fusion protein and challenged intrarectally with repeated low doses of SIVmac.
Cervasi B; Carnathan DG; Sheehan KM; Micci L; Paiardini M; Kurupati R; Tuyishime S; Zhou XY; Else JG; Ratcliffe SJ; Ertl HC; Silvestri G
J Virol; 2013 Sep; 87(17):9420-30. PubMed ID: 23804645
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.
Fuller DH; Shipley T; Allen TM; Fuller JT; Wu MS; Horton H; Wilson N; Widera G; Watkins DI
Virology; 2007 Aug; 364(2):245-55. PubMed ID: 17428516
[TBL] [Abstract][Full Text] [Related]
6. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
7. Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.
Patterson LJ; Malkevitch N; Zhao J; Peng B; Robert-Guroff M
DNA Cell Biol; 2002 Sep; 21(9):627-35. PubMed ID: 12396605
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.
Martins MA; Shin YC; Gonzalez-Nieto L; Domingues A; Gutman MJ; Maxwell HS; Castro I; Magnani DM; Ricciardi M; Pedreño-Lopez N; Bailey V; Betancourt D; Altman JD; Pauthner M; Burton DR; von Bredow B; Evans DT; Yuan M; Parks CL; Ejima K; Allison DB; Rakasz E; Barber GN; Capuano S; Lifson JD; Desrosiers RC; Watkins DI
PLoS Pathog; 2017 Jul; 13(7):e1006529. PubMed ID: 28732035
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers.
Virnik K; Ni Y; Berkower I
Vaccine; 2012 Aug; 30(37):5453-8. PubMed ID: 22776214
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.
Hel Z; Tsai WP; Thornton A; Nacsa J; Giuliani L; Tryniszewska E; Poudyal M; Venzon D; Wang X; Altman J; Watkins DI; Lu W; von Gegerfelt A; Felber BK; Tartaglia J; Pavlakis GN; Franchini G
J Immunol; 2001 Dec; 167(12):7180-91. PubMed ID: 11739541
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.
Virnik K; Ni Y; Berkower I
Vaccine; 2013 Apr; 31(17):2119-25. PubMed ID: 23474312
[TBL] [Abstract][Full Text] [Related]
12. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
[TBL] [Abstract][Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques.
Virnik K; Hockenbury M; Ni Y; Beren J; Pavlakis GN; Felber BK; Berkower I
Retrovirology; 2013 Sep; 10():99. PubMed ID: 24041113
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.
Rud EW; Cranage M; Yon J; Quirk J; Ogilvie L; Cook N; Webster S; Dennis M; Clarke BE
J Gen Virol; 1994 Mar; 75 ( Pt 3)():529-43. PubMed ID: 8126450
[TBL] [Abstract][Full Text] [Related]
16. Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques.
Hel Z; Nacsa J; Tsai WP; Thornton A; Giuliani L; Tartaglia J; Franchini G
Virology; 2002 Dec; 304(1):125-34. PubMed ID: 12490410
[TBL] [Abstract][Full Text] [Related]
17. Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08.
Verrier B; Le Grand R; Ataman-Onal Y; Terrat C; Guillon C; Durand PY; Hurtrel B; Aubertin AM; Sutter G; Erfle V; Girard M
DNA Cell Biol; 2002 Sep; 21(9):653-8. PubMed ID: 12396607
[TBL] [Abstract][Full Text] [Related]
18. A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.
Heeney JL; Koopman G; Rosenwirth B; Bogers W; van Dijk J; Nieuwenhuis I; Niphuis H; ten Haaft P; Hanke T; Rhodes G; Berglund P; Burny A; Bex F; Sutter G; Liljeström P
J Med Primatol; 2000 Aug; 29(3-4):268-73. PubMed ID: 11085589
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
[TBL] [Abstract][Full Text] [Related]
20. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]